This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Sep 2026 consolidated quarter: revenue up 16%, profit after tax up 43% year on year; Rs 1 dividend
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended September 30, 2026 (Rs million): revenue 4,968.21 versus 4,291.91 a year earlier; profit after tax 754.83 versus 528.90, up 42.7%. Operating profit before interest, tax, depreciation and amortisation was 27.0% of revenue, up 1.8 points. Prior figures were restated for unit changes and discontinued operations. Interim dividend Rs 1 per share; record date November 9; auditor changed mid-year; review unmodified.
43% profit growth and the Rs 1 per share interim dividend may support returns, but revenue grew 16% and the auditor changed mid-year.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹496.8 Cr | ₹429.2 Cr | +15.8% |
| Operating profit | ₹93.99 Cr | ₹70.13 Cr | +34.0% |
| Profit after tax | ₹75.48 Cr | ₹52.89 Cr | +42.7% |
| EBITDA margin | 27.0% | 25.2% | +1.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.